Summary Keywords glucagon-like peptide-1, cognitive impairment, diabetes mellitus, mechanism, neuroprotection Citation Dou X, Zhao L, Li J and Jiang Y (2025) Effect and mechanism of GLP-1 on cognitive function in diabetes mellitus
Formularies group medications into different tiers, and insurance companies typically pay more (or all) of the cost of the drugs in the lower tiers (generic drugs) more consistently than those in the higher tiers (brand names, specialty drugs, etc.)
fsus.ncbg.unc.edu Accessed Aug 28, 2024
The Precision Peptide Genetic Test adds personalized insight into how individual genetic variantsincluding GLP1R rs6923761 and GIPR rs1800437influence medication response and optimal dosing pathways
Semaglutide might be better for you if You have type 2 diabetes (additional blood sugar benefits) You prefer a medication with longer clinical history You want proven, consistent results Insurance covers semaglutide but not tirzepatide Tirzepatide might be better for you if You want potentially greater weight loss Youve tried semaglutide without optimal results You have both weight and blood sugar concerns You can tolerate potentially higher initial costs Both medications work best for people who Have a BMI of 30 or higher (or 27+ with weight-related health conditions) Are committed to lifestyle changes Can handle weekly injections Want non-surgical weight loss treatment
However, always consult healthcare provider if pregnant, nursing, or have medical conditions
